Periodontal and peri-implant status and whole salivary interleukin 1-beta levels among individuals using selective serotonin reuptake inhibitors: an observational study
Autor: | Shatha Subhi ALHarthi, Munerah S. BinShabaib, Abdulrahman Alwahibi, Shahinaz Gamal, Eldin Elashiry, Sarah E. Almershed, Haifa Abdulrahman Alkhamis, Lamyia Anweigi |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | BMC Oral Health, Vol 23, Iss 1, Pp 1-8 (2023) |
Druh dokumentu: | article |
ISSN: | 1472-6831 95972528 |
DOI: | 10.1186/s12903-023-02908-0 |
Popis: | Abstract Objective Selective serotonin reuptake inhibitors (SSRI) are commonly used for managing psychological diseases such as depression. These disorders are also directly associated with periodontal and peri-implant diseases, namely periodontitis and peri-implantitis, respectively. It is hypothesized that there is no difference in periodontal and peri-implant clinicoradiographic status and unstimulated whole salivary interleukin (IL)-1β levels in participants using selective serotonin reuptake inhibitors (SSRI) and controls (individuals not using SSRI). The aim of the present observational case-control study was to compare periodontal and peri-implant clinicoradiographic statuses and whole salivary IL-1β in participants using SSRI and controls. Methods Users of SSRI and controls were included. In all participants, periodontal (plaque index [PI], gingival index [GI], probing depth [PD], clinical attachment loss [AL] and marginal bone loss [MBL]) and peri-implant (modified PI [mPI], modified GI [mGI], PD and crestal bone loss [CBL]) were assessed. Unstimulated whole saliva was collected and IL-1β levels were determined. Information related to duration of implants in function, duration of depressive symptoms and treatment of depression was retrieved from healthcare records. Sample-size was estimated using 5% error and group comparisons were performed. P |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |